These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

157 related items for PubMed ID: 9254630

  • 1. Mechanisms of action of bactericidal/permeability-increasing protein BPI on reconstituted outer membranes of gram-negative bacteria.
    Wiese A, Brandenburg K, Carroll SF, Rietschel ET, Seydel U.
    Biochemistry; 1997 Aug 19; 36(33):10311-9. PubMed ID: 9254630
    [Abstract] [Full Text] [Related]

  • 2. Mechanisms of action of the bactericidal/permeability-increasing protein BPI on endotoxin and phospholipid monolayers and aggregates.
    Wiese A, Brandenburg K, Lindner B, Schromm AB, Carroll SF, Rietschel ET, Seydel U.
    Biochemistry; 1997 Aug 19; 36(33):10301-10. PubMed ID: 9254629
    [Abstract] [Full Text] [Related]

  • 3. A peptide derived from human bactericidal/permeability-increasing protein (BPI) exerts bactericidal activity against Gram-negative bacterial isolates obtained from clinical cases of bovine mastitis.
    Chockalingam A, McKinney CE, Rinaldi M, Zarlenga DS, Bannerman DD.
    Vet Microbiol; 2007 Nov 15; 125(1-2):80-90. PubMed ID: 17560054
    [Abstract] [Full Text] [Related]

  • 4. The role of lipopolysaccharides in the action of the bactericidal/permeability-increasing neutrophil protein on the bacterial envelope.
    Weiss J, Muello K, Victor M, Elsbach P.
    J Immunol; 1984 Jun 15; 132(6):3109-15. PubMed ID: 6373924
    [Abstract] [Full Text] [Related]

  • 5. Impact of the glycostructure of amphiphilic membrane components on the function of the outer membrane of Gram-negative bacteria as a matrix for incorporated channels and a target for antimicrobial peptides or proteins.
    Gutsmann T, Seydel U.
    Eur J Cell Biol; 2010 Jan 15; 89(1):11-23. PubMed ID: 19939497
    [Abstract] [Full Text] [Related]

  • 6. Towards antibacterial strategies: studies on the mechanisms of interaction between antibacterial peptides and model membranes.
    Wiese A, Gutsmann T, Seydel U.
    J Endotoxin Res; 2003 Jan 15; 9(2):67-84. PubMed ID: 12803879
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Lipid-mediated resistance of Gram-negative bacteria against various pore-forming antimicrobial peptides.
    Gutsmann T, Hagge SO, David A, Roes S, Böhling A, Hammer MU, Seydel U.
    J Endotoxin Res; 2005 Jan 15; 11(3):167-73. PubMed ID: 15949145
    [Abstract] [Full Text] [Related]

  • 11. Recombinant bactericidal/permeability-increasing protein inhibits endotoxin-induced high-mobility group box 1 protein gene expression in sepsis.
    Zhang LT, Yao YM, Lu JQ, Yan XJ, Yu Y, Sheng ZY.
    Shock; 2008 Feb 15; 29(2):278-84. PubMed ID: 17693935
    [Abstract] [Full Text] [Related]

  • 12. Mechanism of interaction of different classes of cationic antimicrobial peptides with planar bilayers and with the cytoplasmic membrane of Escherichia coli.
    Wu M, Maier E, Benz R, Hancock RE.
    Biochemistry; 1999 Jun 01; 38(22):7235-42. PubMed ID: 10353835
    [Abstract] [Full Text] [Related]

  • 13. Efficacy of bactericidal/permeability-increasing protein in experimental otitis media with effusion in rats: a new therapy for mucosal infections.
    Nell MJ, Grote JJ.
    J Lab Clin Med; 2001 Apr 01; 137(4):303-9. PubMed ID: 11283526
    [Abstract] [Full Text] [Related]

  • 14. Antimicrobial peptide rBPI21: a translational overview from bench to clinical studies.
    Domingues MM, Santos NC, Castanho MA.
    Curr Protein Pept Sci; 2012 Nov 01; 13(7):611-9. PubMed ID: 23116442
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Lipopolysaccharide interaction is decisive for the activity of the antimicrobial peptide NK-2 against Escherichia coli and Proteus mirabilis.
    Hammer MU, Brauser A, Olak C, Brezesinski G, Goldmann T, Gutsmann T, Andrä J.
    Biochem J; 2010 Apr 14; 427(3):477-88. PubMed ID: 20187872
    [Abstract] [Full Text] [Related]

  • 19. Antimicrobial protein rBPI21-induced surface changes on Gram-negative and Gram-positive bacteria.
    Domingues MM, Silva PM, Franquelim HG, Carvalho FA, Castanho MA, Santos NC.
    Nanomedicine; 2014 Apr 14; 10(3):543-51. PubMed ID: 24262996
    [Abstract] [Full Text] [Related]

  • 20. Inhibition of lipid A-mediated type I interferon induction by bactericidal/permeability-increasing protein (BPI).
    Azuma M, Matsuo A, Fujimoto Y, Fukase K, Hazeki K, Hazeki O, Matsumoto M, Seya T.
    Biochem Biophys Res Commun; 2007 Mar 09; 354(2):574-8. PubMed ID: 17239348
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.